A detailed history of American Portfolios Advisors transactions in Novo Nordisk A S stock. As of the latest transaction made, American Portfolios Advisors holds 3,608 shares of NVO stock, worth $315,230. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,608
Holding current value
$315,230
% of portfolio
0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023

BUY
$95.28 - $116.93 $343,770 - $421,883
3,608 New
3,608 $359 Million
Q2 2022

Mar 20, 2023

BUY
$103.24 - $121.81 $64,937 - $76,618
629 Added 17.43%
4,237 $472 Million
Q1 2022

Mar 21, 2023

BUY
$93.1 - $112.54 $41,057 - $49,630
441 Added 12.22%
4,049 $450 Million
Q4 2021

Mar 21, 2023

BUY
$95.88 - $117.08 $65,486 - $79,965
683 Added 18.93%
4,291 $481 Million
Q3 2021

Mar 22, 2023

BUY
$84.42 - $106.62 $14,182 - $17,912
168 Added 4.66%
3,776 $363 Million
Q2 2021

Mar 22, 2023

SELL
$67.66 - $84.76 $30,311 - $37,972
-448 Reduced 12.42%
3,160 $265 Million
Q1 2021

Mar 22, 2023

SELL
$67.06 - $75.82 $37,084 - $41,928
-553 Reduced 15.33%
3,055 $206 Million
Q4 2020

Mar 22, 2023

SELL
$63.89 - $73.8 $35,842 - $41,401
-561 Reduced 15.55%
3,047 $213 Million
Q3 2020

Mar 22, 2023

SELL
$63.69 - $70.22 $40,952 - $45,151
-643 Reduced 17.82%
2,965 $206 Million
Q2 2020

Mar 24, 2023

BUY
$58.54 - $67.94 $6,029 - $6,997
103 Added 4.94%
2,188 $143 Million
Q1 2020

Mar 24, 2023

SELL
$49.46 - $64.78 $75,327 - $98,659
-1,523 Reduced 42.21%
2,085 $126 Million
Q4 2019

Mar 24, 2023

SELL
$49.86 - $58.26 $69,006 - $80,631
-1,384 Reduced 38.36%
2,224 $129 Million
Q3 2019

Mar 24, 2023

BUY
$47.54 - $53.43 $3,898 - $4,381
82 Added 5.66%
1,530 $79.1 Million
Q2 2019

Mar 24, 2023

SELL
$46.79 - $52.47 $101,066 - $113,335
-2,160 Reduced 59.87%
1,448 $73.9 Million
Q1 2019

Mar 24, 2023

BUY
$46.36 - $52.63 $9,828 - $11,157
212 Added 17.29%
1,438 $75.2 Million
Q4 2018

Mar 24, 2023

BUY
$41.54 - $47.25 $9,678 - $11,009
233 Added 23.46%
1,226 $56.5 Million
Q3 2018

Mar 24, 2023

SELL
$46.76 - $51.24 $122,277 - $133,992
-2,615 Reduced 72.48%
993 $46.8 Million
Q2 2018

Mar 24, 2023

SELL
$44.29 - $50.42 $72,192 - $82,184
-1,630 Reduced 44.95%
1,996 $92.1 Million
Q1 2018

Mar 24, 2023

BUY
$48.49 - $58.14 $872 - $1,046
18 Added 0.5%
3,626 $179 Million
Q4 2017

Mar 24, 2023

SELL
$47.53 - $53.73 $32,272 - $36,482
-679
2,929 $157 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.